Valuation: Cellnovo

Market Cap 2.44M 2.17M 2.02M 1.84M 3.47M 235M 3.49M 24.43M 9.5M 120M 9.14M 8.95M 385M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 11.1M 10.35M 9.42M 17.76M 1.2B 17.87M 125M 48.58M 612M 46.77M 45.75M 1.97B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
+1.48%+1.75%+1.51%+64.66% 3,843B
+0.34%-0.14%+9.44%+1,104.07% 454B
+0.13%+3.92%-50.21%+33.06% 431B
+0.87%+8.54%+96.32%+244.07% 330B
+0.97%+8.15%+122.64%+564.85% 277B
+0.61%-0.47%-19.60%+51.67% 239B
+1.27%+0.34%-25.42%+24.02% 139B
+1.76%+6.15%+114.63%+216.05% 133B
-0.29%+3.09%+82.07%+212.23% 99.54B
Average +0.17%+2.40%+36.82%+279.41% 594.5B
Weighted average by Cap. -0.00%+1.25%+11.67%+179.31%

Financials

2018 2019 *
Net sales 3.32M 2.96M 2.76M 2.51M 4.74M 320M 4.77M 33.33M 12.95M 163M 12.47M 12.2M 525M -
Net income -15.94M -14.21M -13.24M -12.05M -22.73M -1.53B -22.86M -160M -62.16M -783M -59.84M -58.54M -2.52B -
Net Debt 10.02M 8.93M 8.33M 7.58M 14.29M 965M 14.38M 101M 39.09M 492M 37.62M 36.81M 1.58B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock